Video yükleniyor...
Video Yüklenemedi
DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇
34,166 görüntüleme • 7 ay önce •via X (Twitter)
0 Yorum
Yorum bulunmuyor
Orijinal gönderinin yorumları burada görünecek



